Cargando…

Suppressing aberrant phospholipase D1 signaling in 3xTg Alzheimer’s disease mouse model promotes synaptic resilience

Current approaches in treatment of Alzheimer’s disease (AD) is focused on early stages of cognitive decline. Identifying therapeutic targets that promote synaptic resilience during early stages may prevent progressive memory deficits by preserving memory mechanisms. We recently reported that the ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bourne, Krystyn Z., Natarajan, Chandramouli, Perez, Carlos X. Medina, Tumurbaatar, Batbayar, Taglialatela, Giulio, Krishnan, Balaji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892889/ https://www.ncbi.nlm.nih.gov/pubmed/31797996 http://dx.doi.org/10.1038/s41598-019-54974-6

Ejemplares similares

Phospholipase D1 Attenuation Therapeutics Promotes Resilience against Synaptotoxicity in 12-Month-Old 3xTg-AD Mouse Model of Progressive Neurodegeneration
por: Natarajan, Chandramouli, et al.
Publicado: (2023)

Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer’s Disease Neuropathology Is Associated with Absence of Synaptic Tau Oligomers
por: Singh, Ayush, et al.
Publicado: (2020)

Near Infrared Light Treatment Reduces Synaptic Levels of Toxic Tau Oligomers in Two Transgenic Mouse Models of Human Tauopathies
por: Comerota, Michele M., et al.
Publicado: (2018)

Elevated phospholipase D isoform 1 in Alzheimer's disease patients' hippocampus: Relevance to synaptic dysfunction and memory deficits
por: Krishnan, Balaji, et al.
Publicado: (2018)

TREM2‐induced activation of microglia contributes to synaptic integrity in cognitively intact aged individuals with Alzheimer's neuropathology
por: Fracassi, Anna, et al.
Publicado: (2022)

Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer’s disease
por: Ye, Minsook, et al.
Publicado: (2016)

Olfactory dysfunction in the 3xTg-AD model of Alzheimer’s disease
por: Mitrano, Darlene A., et al.
Publicado: (2021)

Dopaminergic dysfunction in the 3xTg-AD mice model of Alzheimer’s disease
por: Gloria, Yesica, et al.
Publicado: (2021)

Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer’s disease
por: Marcatti, Michela, et al.
Publicado: (2022)

Hippocampal stem cells promotes synaptic resistance to the dysfunctional impact of amyloid beta oligomers via secreted exosomes
por: Micci, Maria-Adelaide, et al.
Publicado: (2019)

Chronic synaptic insulin resistance after traumatic brain injury abolishes insulin protection from amyloid beta and tau oligomer-induced synaptic dysfunction
por: Franklin, Whitney, et al.
Publicado: (2019)

Hypertension Accelerates Alzheimer’s Disease-Related Pathologies in Pigs and 3xTg Mice
por: Shih, Yao-Hsiang, et al.
Publicado: (2018)

Impaired Spatial Reorientation in the 3xTg-AD Mouse Model of Alzheimer’s Disease
por: Stimmell, Alina C., et al.
Publicado: (2019)

Evaluating the Effect of Interleukin-4 in the 3xTg Mouse Model of Alzheimer’s Disease
por: Dionisio-Santos, Dawling A., et al.
Publicado: (2020)

Systematic Phenotyping and Characterization of the 3xTg-AD Mouse Model of Alzheimer’s Disease
por: Javonillo, Dominic I., et al.
Publicado: (2022)

Spatial memory deficiency early in 6xTg Alzheimer’s disease mouse model
por: Kang, Shinwoo, et al.
Publicado: (2021)

Abnormal whisker movements in the 3xTg‐AD mouse model of Alzheimer's disease
por: Simanaviciute, Ugne, et al.
Publicado: (2022)

Early postnatal defects in neurogenesis in the 3xTg mouse model of Alzheimer’s disease
por: Liu, Yubing, et al.
Publicado: (2023)

Neuroprotective Effect of Nosustrophine in a 3xTg Mouse Model of Alzheimer’s Disease
por: Carrera, Iván, et al.
Publicado: (2023)

Aberrant Expression of GABA-Related Genes in the Hippocampus of 3xTg-AD Model Mice from the Early to End Stages of Alzheimer’s Disease
por: Mori, Hiroaki, et al.
Publicado: (2023)

Selected microRNAs Increase Synaptic Resilience to the Damaging Binding of the Alzheimer’s Disease Amyloid Beta Oligomers
por: Zolochevska, Olga, et al.
Publicado: (2020)

Near infrared light decreases synaptic vulnerability to amyloid beta oligomers
por: Comerota, Michele M., et al.
Publicado: (2017)

Age-Dependent Decline in Synaptic Mitochondrial Function Is Exacerbated in Vulnerable Brain Regions of Female 3xTg-AD Mice
por: Espino de la Fuente-Muñoz, César, et al.
Publicado: (2020)

Gestational high fat diet protects 3xTg offspring from memory impairments, synaptic dysfunction and brain pathology
por: Di Meco, Antonio, et al.
Publicado: (2021)

Temporal and regional progression of Alzheimer’s disease‐like pathology in 3xTg‐AD mice
por: Belfiore, Ramona, et al.
Publicado: (2018)

Early Onset of Sex-Dependent Mitochondrial Deficits in the Cortex of 3xTg Alzheimer’s Mice
por: Djordjevic, Jelena, et al.
Publicado: (2020)

Alterations of the Sympathoadrenal Axis Related to the Development of Alzheimer’s Disease in the 3xTg Mouse Model
por: Muñoz-Montero, Alicia, et al.
Publicado: (2022)

Progressive Vascular Abnormalities in the Aging 3xTg-AD Mouse Model of Alzheimer’s Disease
por: Jullienne, Amandine, et al.
Publicado: (2022)

Alterations in Retinal Signaling Across Age and Sex in 3xTg Alzheimer’s Disease Mice
por: Frame, Gabrielle, et al.
Publicado: (2022)

RAPGEF2 mediates oligomeric Aβ‐induced synaptic loss and cognitive dysfunction in the 3xTg‐AD mouse model of Alzheimer’s disease
por: Jang, You‐Na, et al.
Publicado: (2021)

Treatment of Alzheimer's Disease with Anti-Homocysteic Acid Antibody in 3xTg-AD Male Mice
por: Hasegawa, Tohru, et al.
Publicado: (2010)

Sex Differences in Healthspan Predict Lifespan in the 3xTg-AD Mouse Model of Alzheimer’s Disease
por: Kane, Alice E., et al.
Publicado: (2018)

Exercise and resveratrol increase fracture resistance in the 3xTg-AD mouse model of Alzheimer’s disease
por: Alkhouli, Mustafa F., et al.
Publicado: (2019)

Enhanced susceptibility of triple transgenic Alzheimer’s disease (3xTg-AD) mice to acute infection
por: Montacute, Rebecca, et al.
Publicado: (2017)

Nilotinib Improves Bioenergetic Profiling in Brain Astroglia in the 3xTg Mouse Model of Alzheimer’s Disease
por: Adlimoghaddam, Aida, et al.
Publicado: (2021)

Fingolimod Rescues Memory and Improves Pathological Hallmarks in the 3xTg-AD Model of Alzheimer’s Disease
por: Fagan, Steven G., et al.
Publicado: (2022)

Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Mice
por: Stojakovic, Andrea, et al.
Publicado: (2021)

Gender-Specific Neuroimmunoendocrine Response to Treadmill Exercise in 3xTg-AD Mice
por: Giménez-Llort, Lydia, et al.
Publicado: (2010)

Mesenchymal Stem Cells Preserve Working Memory in the 3xTg-AD Mouse Model of Alzheimer’s Disease
por: Ruzicka, Jiri, et al.
Publicado: (2016)

Microglial Activation in the Retina of a Triple-Transgenic Alzheimer’s Disease Mouse Model (3xTg-AD)
por: Salobrar-García, Elena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pm307dg6omvq70t61iv1gmp74c